BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28341599)

  • 1. Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells.
    Tecalco-Cruz AC; Pérez-Alvarado IA; Ramírez-Jarquín JO; Rocha-Zavaleta L
    Cell Signal; 2017 Jun; 34():121-132. PubMed ID: 28341599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells.
    Castoria G; Giovannelli P; Lombardi M; De Rosa C; Giraldi T; de Falco A; Barone MV; Abbondanza C; Migliaccio A; Auricchio F
    Oncogene; 2012 Nov; 31(46):4868-77. PubMed ID: 22266855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells.
    Lombardi M; Castoria G; Migliaccio A; Barone MV; Di Stasio R; Ciociola A; Bottero D; Yamaguchi H; Appella E; Auricchio F
    J Cell Biol; 2008 Jul; 182(2):327-40. PubMed ID: 18644889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small leucine zipper protein functions as a negative regulator of estrogen receptor α in breast cancer.
    Jeong J; Park S; An HT; Kang M; Ko J
    PLoS One; 2017; 12(6):e0180197. PubMed ID: 28662179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
    Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
    Curr Drug Targets; 2019; 20(6):690-704. PubMed ID: 30324876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha.
    Jang EH; Jang SY; Cho IH; Hong D; Jung B; Park MJ; Kim JH
    Biochem Biophys Res Commun; 2015 Aug; 463(4):917-22. PubMed ID: 26056942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear accumulation of MKL1 in luminal breast cancer cells impairs genomic activity of ERα and is associated with endocrine resistance.
    Jehanno C; Fernandez-Calero T; Habauzit D; Avner S; Percevault F; Jullion E; Le Goff P; Coissieux MM; Muenst S; Marin M; Michel D; Métivier R; Flouriot G
    Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194507. PubMed ID: 32113984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
    Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
    Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered target gene regulation controlled by estrogen receptor-alpha concentration.
    Fowler AM; Solodin NM; Valley CC; Alarid ET
    Mol Endocrinol; 2006 Feb; 20(2):291-301. PubMed ID: 16179380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 14-3-3β in transcriptional activation of estrogen receptor α and its involvement in proliferation of breast cancer cells.
    Kim Y; Kim H; Jang SW; Ko J
    Biochem Biophys Res Commun; 2011 Oct; 414(1):199-204. PubMed ID: 21946067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
    Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.